Robert Lyne
Patrimonio netto: 275 574 $ in data 30/06/2026
Patrimonio netto: 275 574 $ in data 30/06/2026
Robert William Henry Lyne is currently Chief Executive Officer & Director at PureTech Health Plc starting in 2025.
He is CEO and General Counsel at Arix Bioscience since 2021.
He serves as Director at Arix Bioscience Holdings Ltd. since 2017, Director at Seaport Therapeutics, Inc., and Board Member at Arix Capital Management Ltd. Formerly, Mr. Lyne was Chief Executive Officer at Arix Bioscience Plc from 2021 to 2023 and worked as an Associate at Bird & Bird LLP.
Education includes undergraduate studies at the University of Oxford and graduate studies at Oxford Brookes University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
PURETECH HEALTH PLC 0,06% | 08/07/2026 | 151.112 ( 0,06% ) | 275 574 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PURETECH HEALTH PLC | Amministratore Delegato | 15/07/2025 |
Arix Capital Management Ltd.
Arix Capital Management Ltd. Investment ManagersFinance Arix Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, diagnostics, medical technology, biotech, pharmaceuticals and life science services. It provides financing for early & later stage capital requirements with an investment size of GBP 0.5 - 5 million and also makes follow-on investments. | Direttore/Membro del Consiglio | - |
Arix Bioscience /Venture Capital/
Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience invests in companies located in the United Kingdom. The firm focuses on the therapeutics sector. It participates in early stage capital requirements. | Amministratore Delegato | 01/10/2021 |
Arix Bioscience Holdings Ltd.
Arix Bioscience Holdings Ltd. Medical/Nursing ServicesHealth Services Provides support services to healthcare and lift science business | Direttore/Membro del Consiglio | 06/12/2017 |
| Società | Posizione | Fine |
|---|---|---|
| ARIX BIOSCIENCE PLC | Amministratore Delegato | 01/12/2023 |
Bird & Bird LLP
Bird & Bird LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Brookes University
Oxford Brookes University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bird & Bird LLP
Bird & Bird LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Commercial Services |
Arix Capital Management Ltd.
Arix Capital Management Ltd. Investment ManagersFinance Arix Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, diagnostics, medical technology, biotech, pharmaceuticals and life science services. It provides financing for early & later stage capital requirements with an investment size of GBP 0.5 - 5 million and also makes follow-on investments. | Finance |
PureTech Health Plc
PureTech Health Plc BiotechnologyHealth Technology Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune | Health Technology |
Arix Bioscience Plc
Arix Bioscience Plc Investment ManagersFinance Operates as a global venture capital firm | Finance |
Arix Bioscience Holdings Ltd.
Arix Bioscience Holdings Ltd. Medical/Nursing ServicesHealth Services Provides support services to healthcare and lift science business | Health Services |
Arix Bioscience /Venture Capital/
Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience invests in companies located in the United Kingdom. The firm focuses on the therapeutics sector. It participates in early stage capital requirements. | Finance |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale